OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2022
(4)
2025
(3)
2021
(2)
2020
(2)
2023
(1)
2018
(1)
2016
(1)
2003
(1)
2000
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Implication of the NLRP3 Inflammasome in Bovine Age-Related Sarcopenia.
Not available
S-EPMC8036417
|
biostudies-literature
Cite
RNAScope
in situ
Hybridization as a Novel Technique for the Assessment of c-KIT mRNA Expression in Canine Mast Cell Tumor.
Not available
S-EPMC7921150
|
biostudies-literature
Cite
Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.
Not available
S-EPMC150734
|
biostudies-literature
Cite
Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
Not available
S-EPMC102181
|
biostudies-literature
Cite
Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study.
Not available
S-EPMC7690395
|
biostudies-literature
Cite
Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study.
Not available
S-EPMC9325225
|
biostudies-literature
Cite
Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2.
Not available
S-EPMC8946502
|
biostudies-literature
Cite
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.
Not available
S-EPMC9512829
|
biostudies-literature
Cite
Programmed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study.
Not available
S-EPMC12183328
|
biostudies-literature
Cite
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.
Not available
S-EPMC5341934
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets